Position in ROIV
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$8,068
+$1,753 QoQ
Shares Held
228
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#417
of 494 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Clearstead Trust, LLC holds $1,415,355 across 17 Biotechnology names. ROIV ranks #7 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,940 | $1,186,058 | |
| 2 | ENTA |
Enanta Pharmaceuticals Inc
|
5,064 | $73,833 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
116 | $57,620 | |
| 4 | INCY |
Incyte Corp
|
141 | $15,983 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
63 | $15,181 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
80 | $14,982 | |
| 7 | ROIV |
Roivant Sciences Ltd.
This page
|
228 | $8,068 | |
| 8 | RPRX |
Royalty Pharma plc
|
132 | $7,401 |
All Filings in ROIV
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,068 | 228 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $6,315 | 228 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $4,947 | 228 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $1,573 | 104 | Shares | Sole | 2025-11-10 | |
| No filing history on record for this holder in this stock. | ||||||